Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2016-10-13

Clinical Trial Update: A Study to Assess Safety and Efficacy of a Novel Treatment, Keratinocyte Growth Factor (KGF), in Asthmatic Patients [Phase 2]

View source ↗

Summary

This clinical trial update reports the completion of a Phase 2 study assessing the safety and efficacy of Keratinocyte Growth Factor (KGF) in patients with asth…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Keratinocyte Growth Factor (KGF) (keratinocyte growth factor)

Snippet

Sponsor: University Hospital Southampton NHS Foundation Trust | Conditions: Bronchial Asthma | Phase 2 | Status: COMPLETED